Biography
Geoffrey’s roles include, preparing progress reports for national reviews and donors, he has investigated multiple outbreaks, including Rift Valley Fever(2020), Brucellosis(2020), Crimean hemorrhagic fever(2018/19), Anthrax (2019 & 2021), Measles (2020), Cholera in Kampala (2015), HEV Outbreak (2014), COVID-19 outbreaks, MDR TB outbreak, EVD 2014 and 2024. Previously FETP Fellow, worked for The AIDS support organization, Infectious diseases. Geoffrey current work at National TB Program as an epidemiologist.
Key Impacts
Chest X-ray and Xpert MTB Rif-Ultra more accurate but costlier than symptom-based screening for same day TB screening, diagnosis and treatment initiation
In the short term, the mobile TB clinic model proved costly and exceeded typical benchmarks. We recommend scaling up this intervention beyond 6 months to maximize efficiencies and lower per-person costs, as marginal costs are expected to decrease significantly with increase in the number of people screened and treated, thereby averting future transmission and offsetting future societal burdens.
Source: Conference 2024
Repeated community-wide screening for tuberculosis: Impact on burden
These findings indicate no substantial reduction in TB burden over the study period, nor a differential impact of the intervention, suggesting limited effectiveness of increased visits in reducing TB burden. Longer period for study or bigger studies may provide clues to this evidence.
Source: Conference 2024
Emerging hotspots of TB in Uganda: Insights from spatiotemporal analysis
The hotspots have highlighted areas where the results of epidemiological evidence can start to manifest in data, future iterations of this model could be integrated into the national TB surveillance framework for near-real-time hotspot monitoring and resource allocation.
Source: Conference 2024